Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
136.01
-0.64 (-0.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
Jazz Pharmaceuticals Market Cap
Jazz Pharmaceuticals has a market cap or net worth of $8.22 billion as of February 21, 2025. Its market cap has increased by 4.73% in one year.
Market Cap
8.22B
Enterprise Value
11.81B
1-Year Change
4.73%
Ranking
Category
Stock Price
$136.01
Market Cap Chart
Since June 1, 2007, Jazz Pharmaceuticals's market cap has increased from $435.30M to $8.22B, an increase of 1,788.91%. That is a compound annual growth rate of 18.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 8.22B | 10.44% |
| Dec 31, 2024 | 7.45B | -3.86% |
| Dec 29, 2023 | 7.74B | -22.80% |
| Dec 30, 2022 | 10.03B | 28.09% |
| Dec 31, 2021 | 7.83B | -14.84% |
| Dec 31, 2020 | 9.20B | 8.89% |
| Dec 31, 2019 | 8.45B | 12.94% |
| Dec 31, 2018 | 7.48B | -7.37% |
| Dec 29, 2017 | 8.07B | 23.62% |
| Dec 30, 2016 | 6.53B | -24.46% |
| Dec 31, 2015 | 8.64B | -12.72% |
| Dec 31, 2014 | 9.90B | 35.42% |
| Dec 31, 2013 | 7.31B | 137.27% |
| Dec 31, 2012 | 3.08B | 89.28% |
| Dec 30, 2011 | 1.63B | 112.63% |
| Dec 31, 2010 | 765.90M | 213.64% |
| Dec 31, 2009 | 244.20M | 340.00% |
| Dec 31, 2008 | 55.50M | -84.62% |
| Dec 31, 2007 | 360.90M | -17.09% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |